ACA
QTTB icon

Acorn Capital Advisors’s Q32 Bio QTTB Stock Holding History

Acorn Capital Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.75M Sell
216,171
-98,881
-31% -$826K 0.75% 16
2026
Q1 		$2.02M Sell
315,052
-178,373
-36% -$847K 0.57% 17
2025
Q4 		$1.64M Sell
493,425
-310,000
-39% -$876K 0.56% 18
2025
Q3 		$1.59M Hold
803,425
– – 0.81% 17
2025
Q2 		$1.2M Hold
803,425
– – 0.78% 19
2025
Q1 		$1.33M Hold
803,425
– – 0.88% 20
2024
Q4 		$2.76M Buy
+803,425
New +$25.4M 1.49% 17

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acorn Capital Advisors's QTTB Position: Q2 2026 in Review

Acorn Capital Advisors reduced its Q32 Bio (QTTB) stake by 31% in Q2 2026, selling an estimated $826K and leaving 216,171 shares worth $2.75M. The position accounts for 0.75% of the portfolio, ranked #16.

Acorn Capital Advisors first reported a position in QTTB in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.76M in Q4 2024. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Acorn Capital Advisors held 216,171 shares of Q32 Bio worth $2.75M as of Q2 2026.
  • Acorn Capital Advisors sold 98,881 Q32 Bio shares in Q2 2026, an estimated $826K.
  • Q32 Bio made up 0.75% of Acorn Capital Advisors's portfolio in Q2 2026, its #16 holding.
  • Acorn Capital Advisors first reported a position in Q32 Bio in Q4 2024 and has held it in 7 quarters since.
  • Acorn Capital Advisors's Q32 Bio position peaked at $2.76M in Q4 2024.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Acorn Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.